ANI Pharmaceuticals Inc. (ANIP) - 5i Research

ANI Pharmaceuticals Inc. (ANIP $81.04)
- $81.04 Cap: $1.78B
- View ANIP Profile
- View Questions on ANIP

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Supernus Pharmaceuticals Inc. (SUPN $51.17)
- $51.17 Cap: $2.93B
- View SUPN Profile
- View Questions on SUPN
ANI Pharmaceuticals Inc. (ANIP $81.04)
- $81.04 Cap: $1.78B
- View ANIP Profile
- View Questions on ANIP

Q: Hi,
I am thinking to buy one of these.
What would be better buy and why?

Thank you.
Milan

Read Answer Asked by Milan on February 01, 2018

Lam Research Corporation (LRCX $200.96)
- $200.96 P/E (TTM): 45.69X Cap: $255.07B
- View LRCX Profile
- View Questions on LRCX
O'Reilly Automotive Inc. (ORLY $91.63)
- $91.63 P/E (TTM): 31.31X Cap: $76.68B
- View ORLY Profile
- View Questions on ORLY
ANI Pharmaceuticals Inc. (ANIP $81.04)
- $81.04 Cap: $1.78B
- View ANIP Profile
- View Questions on ANIP

Q: Your opinion on these 3 US stocks please?
1) LRCX
2) ANIP
3) ORLY

Read Answer Asked by Nino on January 23, 2018

Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use